Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/25/2012EP2444071A1 Minicapsule formulations
04/25/2012EP2444068A1 Brimonidine gel composition
04/25/2012EP2444067A1 Anhydrous gel comprising mupirocin
04/25/2012EP2444065A1 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
04/25/2012EP2444061A1 Apigenin-containing composition
04/25/2012EP2443929A1 Inhibitors of Bruton's Tyrosine Kinase
04/25/2012EP2443926A2 Cyclopamine analogs
04/25/2012EP2443247A1 Improved method for quantifying dna in a biological sample
04/25/2012EP2443246A1 Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
04/25/2012EP2443238A2 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
04/25/2012EP2443237A2 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
04/25/2012EP2443134A2 NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF
04/25/2012EP2443127A2 Compositions and methods for cyclofructans as separation agents
04/25/2012EP2443126A1 Simalikalactone e and use thereof as a medicament
04/25/2012EP2443125A2 Camptothecin derivatives
04/25/2012EP2443124A1 Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
04/25/2012EP2443123A2 Small molecule inhibitors of spleen tyrosine kinase (syk)
04/25/2012EP2443122A1 Diazahomoadamantane derivatives and methods of use thereof
04/25/2012EP2443121A2 Gamma secretase modulators
04/25/2012EP2443120A2 New crystalline form of pemirolast
04/25/2012EP2443119A1 Gamma secretase modulators
04/25/2012EP2443118A1 Gamma secretase modulators
04/25/2012EP2443117A1 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
04/25/2012EP2443116A1 Thiadiazole derivatives and their use for the treatment of disorders mediated by slpl receptors
04/25/2012EP2443115A1 Compounds
04/25/2012EP2443113A1 Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders
04/25/2012EP2443112A1 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
04/25/2012EP2443111A1 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
04/25/2012EP2443110A1 S1p1 agonists comprising a bicyclic n-containing ring
04/25/2012EP2443108A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
04/25/2012EP2443106A1 Heterocyclylaminopyrimidines as kinase inhibitors
04/25/2012EP2443105A1 Novel phenylimidazole derivative as pde10a enzyme inhibitor
04/25/2012EP2443104A1 Disubstituted phthalazine hedgehog pathway antagonists
04/25/2012EP2443103A1 Oxabicyclo [4.1.o]hept-b-en-s-ylcarbamoyl derivatives inhibiting the nuclear factor-kappa(b) - (nf-kb)
04/25/2012EP2443100A2 Compounds which selectively modulate the cb2 receptor
04/25/2012EP2443099A1 Antifungal 1, 2, 4-triazolyl derivatives having a 5- sulfur substituent
04/25/2012EP2443098A1 Antifungal 1, 2, 4-triazolyl derivatives
04/25/2012EP2443097A1 Antifungal 1, 2, 4-triazolyl derivatives
04/25/2012EP2443096A1 Pyrazine carboxamides as inhibitors of dgat1
04/25/2012EP2443095A1 Sulfonamides and sulfamides as zap-70 inhibitors
04/25/2012EP2443094A2 Process for the preparation of telmisartan
04/25/2012EP2443093A1 Process for the preparation of pyrazole derivatives
04/25/2012EP2443092A1 Bicyclic and tricyclic compounds as kat ii inhibitors
04/25/2012EP2443091A1 Anthelmintic agents and their use
04/25/2012EP2443089A1 Deuterated i soindoline- i, 3-dione derivatives as pde4 and tnf-alpha inhibitors
04/25/2012EP2442871A1 Inhibition of nfk-b mediated virus replication with specific oligosaccharides
04/25/2012EP2442830A2 Hemostatic material and delivery device
04/25/2012EP2442826A1 Influenza vaccine, composition, and methods of use
04/25/2012EP2442817A1 Tellurium-containing compounds for treating viral infections
04/25/2012EP2442816A1 Compositions and methods for modulation of smn2 splicing in a subject
04/25/2012EP2442815A2 Sox11 activating agents and uses thereof
04/25/2012EP2442814A2 Bifidobacteria for treating diabetes and related conditions
04/25/2012EP2442813A1 A medicinal anti acne cream comprising chitosan and a process to make it
04/25/2012EP2442812A1 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
04/25/2012EP2442811A1 Theobromine for the treatment of cough
04/25/2012EP2442810A2 Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
04/25/2012EP2442809A1 Inhibitors of influenza viruses replication
04/25/2012EP2442808A2 Composition for transporting orotic acid across the blood-brain barrier
04/25/2012EP2442807A1 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
04/25/2012EP2442806A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
04/25/2012EP2442805A1 Nanodispersion of a drug and process for its preparation
04/25/2012EP2442803A1 Modulation of systemic exposure to rifaximin
04/25/2012EP2442802A1 Methods and compositions for increasing trichogenic potency of dermal cells
04/25/2012EP2442801A1 A process for preparing trichloroammineplatinate salt and the products obtained therein
04/25/2012EP2442800A2 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
04/25/2012EP2442799A2 Solid pharmaceutical composition comprising rivaroxaban
04/25/2012EP2442796A2 Nanoparticulate candesartan cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them
04/25/2012EP2442795A2 Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them
04/25/2012EP2442794A1 Nanoparticulate telmisartan compositions and process for the preparation thereof
04/25/2012EP2442793A1 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
04/25/2012EP2442791A1 Dosage forms of apixaban
04/25/2012EP2442790A1 Aqueous pharmaceutical compositions containing borate-polyol complexes
04/25/2012EP2442789A1 Stable nanoparticulate drug suspension
04/25/2012EP2442785A1 Agent for preventing or treating abnormality in skin water permeation function
04/25/2012EP2442784A1 Compositions and methods for inhibiting par2 activation of keratinocytes
04/25/2012EP2442771A1 Silicone scar treatment preparation
04/25/2012EP2442673A1 Nutritional powders comprising spray dried hmb
04/25/2012EP2442668A1 Buffered gum base for high ph release
04/25/2012EP2442667A1 Nmp-enriched extract
04/25/2012EP2442657A1 Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
04/25/2012EP2442655A1 Compositions and methods for treating amyotrophic lateral sclerosis
04/25/2012EP2442651A1 Treatment of multiple sclerosis with laquinimod
04/25/2012EP2442650A1 Sublingual apomorphine
04/25/2012EP2442649A1 The use of metabotropic glutamate receptor potentiators for reducing nicotine dependence
04/25/2012EP2442647A2 Dithiol compounds, derivatives, and uses therefor
04/25/2012EP2442646A1 Ectoparasiticidal methods and formulations
04/25/2012EP2442645A1 Choline esters
04/25/2012EP2442644A1 Opsin-binding ligands, compositions and methods of use
04/25/2012EP2324016B1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
04/25/2012EP2307372B1 Heterocyclic antiviral compounds
04/25/2012EP2307354B1 Process for preparing a benzoylbenzeneacetamide derivative
04/25/2012EP2279187B1 Spirocyclic derivatives as histone deacetylase inhibitors
04/25/2012EP2247586B1 2-aza-bicyclo[2.2.1]heptane derivatives
04/25/2012EP2245027B1 Hepatitis c virus inhibitors
04/25/2012EP2225210B1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents
04/25/2012EP2219652B1 Phospholipid compositions and uses thereof
04/25/2012EP2178519B1 Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer
04/25/2012EP2151239B1 Hydrochloric piperphentonamine freeze-dried powder injection, preparation methods and uses thereof
04/25/2012EP2146727B1 High viscosity macromolecular compositions for treating ocular conditions
04/25/2012EP2129375B1 Imidazo[1,2-a]pyridines and their use as pharmaceuticals
1 ... 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 ... 7860